Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19
SAA Egloff, A Junglen, JSA Restivo… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Evidence supporting convalescent plasma (CP), one of the first
investigational treatments for coronavirus disease 2019 (COVID-19), has been inconclusive …
investigational treatments for coronavirus disease 2019 (COVID-19), has been inconclusive …
Association of convalescent plasma treatment with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19 in the community setting
SAA Egloff, A Junglen, JSA Restivo, M Wongskhaluang… - medRxiv, 2021 - medrxiv.org
Background Convalescent plasma (CP) quickly emerged as one of the first investigational
treatment options for COVID-19. Evidence supporting CP for treating patients hospitalized …
treatment options for COVID-19. Evidence supporting CP for treating patients hospitalized …